2017 Oncofertility Conference Agenda Now Available!

The agenda for the 2017 Oncofertility Conference is now online! We are so excited to host the 11th annual meeting of the field on November 14-16, 2017 in Chicago, IL. The agenda is filled with a full-day of education sessions including a hands-on training course and a variety of breakout sessions, followed by two full days of exciting lectures highlighting recent scientific breakthroughs and advances in the clinic. View the complete agenda here

April VGR: Oncofertility in Brazil and Latin America

On Wednesday, April 12, Dr. Jhenifer Rodrigues, who founded the Brazilian Oncofertility Consortium and subsequently, the Latin American Oncofertility Network, delivered the VGR. Her talk, The Oncofertility Field Expansion throughout Brasil and Latin America, gave an overview of oncofertility practices in Central and South America and she explained how she started the Latin America Network and the programs they offer. The VGR is now available for anyone to view online at anytime. Click here to watch this presentation in its entirety! 

Publication in PNAS

Dr. Francesca Duncan and her colleagues recently published in the Proceedings of the National Academy of Sciences (PNAS). 

This paper "mTORC1/2 Inhibition Preserves Ovarian Function and Fertility during Genotoxic Chemotherapy" is significant for the following reasons: "A major unresolved issue for premenopausal women undergoing chemotherapy is infertility due to the loss of nonrenewable ovarian primordial follicles. We show that pharmacologic down-regulation of the mammalian/mechanistic target of rapamycin (mTOR) pathway during chemotherapy in a mouse model prevents activation of primordial follicles, preserves ovarian function, and maintains normal fertility using clinically available inhibitors of mTOR complex (C)1 and mTORC1/2. These findings represent a feasible pharmacologic approach for preservation of ovarian function and fertility during treatment with conventional chemotherapy."

New Report in Toxicological Sciences

Drs. Teresa Woodruff and Shuo Xiao recently published in Toxicological Sciences, which is one of the top journals in toxicology field. This paper examined doxorubicin and its effect on follicle function and oocyte health. Here is more information about the paper from its author Dr. Shuo Xiao:

Watch the March VGR Now!

The March VGR is now available online. Dr. Nao Suzuki presented an overview of the Japan Society for Fertility Preservation. His talk focused on the need for fertility preservation in Japan and history of JSFP. He also included an impressive array of the JSFP programs and the seminars they have hosted since their inception. JSFP is one of the most active Oncofertility Global Partners and we applaud them on all of their efforts. Click here to watch the presentation in its entirety. 

Dr. Jhenifer Rodrigues will deliver the April VGR and give updates from Brazil and Latin America!

Stay tuned for the announcement of the May 2017-June 2018 VGR Series. 

LIVESTRONG launches new online training

LIVESTRONG has launched a dynamic online training for health professionals focused on issues related to cancer treatment and fertility.

Even though more than 150,000 people diagnosed with cancer during their reproductive years, studies have found that health care professionals are still not informing nor referring patients to fertility preservation services at an acceptable rate. The LIVESTRONG Fertility Training for Healthcare Professionals was created to address this issue. The training helps health care providers:

New Publication on Adoption Attitudes among Cancer Survivors

In January, 2017, Jessica R. Gorman from Oregon State University and colleagues published a study in the Journal of Cancer Survivorship comparing adoption considerations between female young adult cancer survivors and women of the same age in the general population. This study found that among cancer survivors, 81.6% said that they would consider adoption compared to 40.3% of women in the general population. In addition, cancer survivors were asked what their concerns were about adoption, and 48% said their desire for biological children was a concern compared to 67% of women in the general population. Additional concerns among cancer survivors included expense of adoption (45%), concern about not being perceived as a good candidate by an adoption agency (41%), and not having enough information about the adoption process (39%).